Real-time FMRI Feedback Impacts Brain Activation, Results in Auditory Hallucinations Reduction: Part 1: Superior Temporal Gyrus -Preliminary Evidence
Overview
Authors
Affiliations
Auditory hallucinations (AH) are one of the core symptoms of schizophrenia (SZ) and constitute a significant source of suffering and disability. One third of SZ patients experience pharmacology-resistant AH, so an alternative/complementary treatment strategy is needed to alleviate this debilitating condition. In this study, real-time functional Magnetic Resonance Imaging neurofeedback (rt-fMRI NFB), a non-invasive technique, was used to teach 10 SZ patients with pharmacology-resistant AH to modulate their brain activity in the superior temporal gyrus (STG), a key area in the neurophysiology of AH. A functional task was designed in order to provide patients with a specific strategy to help them modify their brain activity in the desired direction. Specifically, they received neurofeedback from their own STG and were trained to upregulate it while listening to their own voice recording and downregulate it while ignoring a stranger's voice recording. This guided performance neurofeedback training resulted in a) a significant reduction in STG activation while ignoring a stranger's voice, and b) reductions in AH scores after the neurofeedback session. A single, 21-minute session of rt-fMRI NFB was enough to produce these effects, suggesting that this approach may be an efficient and clinically viable alternative for the treatment of pharmacology-resistant AH.
Mindfulness-based Neurofeedback: A Systematic Review of EEG and fMRI studies.
Treves I, Greene K, Bajwa Z, Wool E, Kim N, Bauer C bioRxiv. 2024; .
PMID: 39314394 PMC: 11419071. DOI: 10.1101/2024.09.12.612669.
Kruse E, Saxena A, Shovestul B, Dudek E, Reda S, Dong J Schizophr Res Cogn. 2024; 38:100329.
PMID: 39290206 PMC: 11406017. DOI: 10.1016/j.scog.2024.100329.
Neuroimaging for precision medicine in psychiatry.
Williams L, Whitfield Gabrieli S Neuropsychopharmacology. 2024; 50(1):246-257.
PMID: 39039140 PMC: 11525658. DOI: 10.1038/s41386-024-01917-z.
Morfini F, Bauer C, Zhang J, Whitfield-Gabrieli S, Shinn A, Niznikiewicz M Schizophr Res. 2024; 270:358-365.
PMID: 38968807 PMC: 11531859. DOI: 10.1016/j.schres.2024.06.036.
Fagerland S, Berntsen H, Fredriksen M, Endestad T, Skouras S, Rootwelt-Revheim M J Electr Bioimpedance. 2024; 15(1):41-62.
PMID: 38827812 PMC: 11141335. DOI: 10.2478/joeb-2024-0006.